Capital Fund Management S.A. Amarin Corp Plcuk Transaction History

Capital Fund Management S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$4.26 - $6.5 $149,189 - $227,636	-35,021 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$5.03 - $8.8 $176,155 - $308,184	35,021 New	35,021 $217,000
Q4 2020 Feb 12, 2021	SELL	$4.04 - $5.31 $246,876 - $324,483	-61,108 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.64 - $7.76 $29,917 - $63,779	8,219 Added 15.54%	61,108 $257,000
Q2 2020 Aug 13, 2020	BUY	$4.78 - $8.26 $252,809 - $436,863	52,889 New	52,889 $365,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $206M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.